Delineating the impact of neuroantigen vs genetic diversity on MP4-induced EAE of C57BL/6 and B6.129 mice

APMIS

Volumn 117, Issue 12, 2009, Pages 923-935

  Kuerten, Stefanie ^a,b   Rodi, Michael ^a   Javeri, Sita ^a   Gruppe, Traugott L ^a   Tary Lehmann, Magdalena ^b   Lehmann, Paul V ^b   Addicks, Klaus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B6.129; C57BL 6; EAE; MP4; Multiple sclerosis

Indexed keywords

BRAIN ANTIGEN; HYBRID PROTEIN; MP4 FUSION PROTEIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; EXPERIMENTAL MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ANIMALS; ANTIGENIC VARIATION; ANTIGENS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; RECOMBINANT FUSION PROTEINS;

EID: 70450199772     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02555.x     Document Type: Article

References (41)

1. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 47 : 707 717.
2. Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis lesions: implications for diagnosis and therapy. Trends Mol Med 2001 7 : 115 121.
3. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005 23 : 683 747.
4. Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 2009 65 : 239 248.
5. Goverman J, Brabb T. Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis. Lab Anim Sci 1996 46 : 482 492.
6. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006 129 : 1953 1971.
7. Zamvil SS, Mitchell DJ, Moore AC, Kitamura K, Steinmann L, Rothbard JB. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986 324 : 258 260.
8. Furlan R, Cuomo C, Martino G. Animal models of multiple sclerosis. Methods Mol Biol 2009 549 : 157 173.
9. Fritz RB, Chou CH, McFarlin DE. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL7J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol 1983 130 : 191 194.
10. Greer JM, Kuchroo VK, Sobel RA, Lees MB. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J Immunol 1992 149 : 783 788.
11. Tuohy VK, Sobel RA, Lu Z, Laursen RA, Lees MB. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J Neuroimmunol 1992 39 : 67 74.
12. Jabs C, Greve B, Chang TT, Sobel RA, Sharpe AH, Kuchroo VK. Genetic background determines the requirement for B7 costimulation in induction of autoimmunity. Eur J Immunol 2002 32 : 2687 2697.
13. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Nat Acad Sci USA 1992 89 : 574 578.
14. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C. Animal models. Ann Neurol 1994 36 (Suppl. S47 53.
15. Gasser DL, Goldner-Sauve A, Hickey WF. Genetic control of resistance to clinical EAE accompanied by histological symptoms. Immunogenetics 1990 31 : 377 382.
16. Skundric DS, Huston K, Shaw W, Tse HY, Raine CS. Experimental allergic encephalo-myelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Lab Invest 1994 71 : 671 679.
17. Fritz RB, Zhao ML. Active und passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice. J Neurosc Res 1996 45 : 471 474.
18. Mendel I, de Rosbo NK, Ben Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 1995 25 : 1951 1959.
19. Hjelmstrom P, Juedes AE, Fjell J, Ruddle NH. B-cell-deficient mice develop experimental allergic encephalomyelitis with immunizing doses of myelin basic protein. Proc Soc Exp Biol Med 1998 149 : 4480 4483.
20. Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 1997 75 : 77 88.
21. Oliver AR, Lyon GM, Ruddle NH. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol 2003 171 : 462 468.
22. Kuerten S, Kostova-Bales DA, Frenzel LP, Tigno JT, Tary-Lehmann M, Angelov DN, et al. MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. J Neuroimmunol 2007 189 : 31 40.
23. Mix E, Meyer-Rienecker H, Zettl UK. Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations. J Neurol 2008 255 : 7 14.
24. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002 168 : 4173 4183.
25. Kuerten S, Lichtenegger FS, Faas S, Angelov DN, Tary-Lehmann M, Lehmann PV. MBP-PLP fusion protein-induced EAE in C57BL/6 mice. J Neuroimmunol 2006 177 : 99 111.
26. Kuerten S, Javeri S, Tary-Lehmann M, Lehmann PV, Angelov DN. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. Clin Immunol 2008 129 : 256 267.
27. Elliott EA, McFarland HI, Nye SH, Cofiell R, Wilson TM, Wilkins JA, et al. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 1996 98 : 1602 1612.
28. Sriram S, Steiner I. Experimental allergic encephalomyelitis, a misleading model of multiple sclerosis. Ann Neurol 2005 58 : 939 945.
29. Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 2006 60 : 12 21.
30. Friese M, Montalban X, Willcox N, Bell J, Martin R, Fugger L. The value of animal models for drug development in multiple sclerosis. Brain 2009 129 : 1940 1952.
31. Weissert R, Wallström E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, et al. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 1998 102 : 1265 1273.
32. Lichtenegger FS, Kuerten S, Faas S, Boehm BO, Tary-Lehmann M, Lehmann PV. Dissociation of experimental allergic encephalomyelitis protective effect and allergic side reactions in tolerization with neuroantigen. J Immunol 2007 178 : 4749 4756.
33. Bernard CC. Experimental autoimmune encephalomyelitis in mice, genetic control of susceptibility. J Immunogenet 1976 3 : 263 274.
34. Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med 2000 6 : 56 61.
35. Gould KE, Swanborg RH. T and B cell responses to myelin basic protein and encephalitogenic epitopes. J Neuroimmunol 1993 46 : 193 198.
36. Figueiredo AC, Cohen IR, Mor F. Diversity of the B cell repertoire to myelin basic protein in rat strains susceptible and resistant to EAE. J Autoimmun 1999 12 : 13 25.
37. Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies. J Neurosci Methods 2007 163 : 245 254.
38. Berard JL, Wolak K, Fournier S, David S. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia 2009 [Epub ahead of print].
39. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997 76 : 355 364.
40. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 1993 23 : 1364 1372.
41. + T cells specific for an astrocyte protein, S100 beta. J Neural Transm Suppl 1997 49 : 43 51.